Introduction {#sec0001}
============

*Campylobacter* infections are among the leading zoonotic agents causing acute gastroenteritis in the developed countries ([@bib0012], [@bib0041], [@bib0054]). Among *Campylobacter* spp., *C. jejuni* is mostly associated with human and other domesticated animal\'s enteritis, followed by *C. coli, C. upsaliensis*, and other species ([@bib0012], [@bib0033], [@bib0039], [@bib0041]). Campylobacters, present in the gastrointestinal tract of different domestic and wild animals, are widely distributed in nature ([@bib0029]). Dog ownership has been shown to significantly increase the risk for pet-associated human *C. jejuni / coli* infection ([@bib0040]). There are a number of reports of isolation of identical strains in humans and their pets ([@bib0012], [@bib0023]). The prevalence of *Campylobacter* spp. in dogs is variable, ranging from 4.81% ([@bib0003]) to 87% ([@bib0001]). The bacterium has been isolated from both diarrheic ([@bib0025]) and asymptomatic carrier dogs ([@bib0001], [@bib0045], [@bib0057]). Moreover, *Campylobacter* spp*.* are reported to be isolated in up to 56.0% of healthy dogs ([@bib0002], [@bib0016], [@bib0031], [@bib0052], [@bib0054]). In the last few years, members of *Campylobacter* spp. have shown an increasing level of resistant to antibacterials, especially to erythromycin, fluoroquinolones and betalactams ([@bib0017]). Occurrence of resistance is mainly associated with the use of macrolides and quinolones in veterinary medicine ([@bib0020], [@bib0031], [@bib0054]).

Dogs are among the most popular companion animals in many parts of the world including India, and their ownership is beneficial to the physical and psychological health, emotional protection and social interaction of humans ([@bib0037]). Despite the benefits derived from the dogs, the transmission of zoonotic agents, including *Campylobacter* spp, is a risk and approximately 6% of human campylobacteriosis cases are reported due to contact with pets ([@bib0029], [@bib0049]). Hence, studies on the epidemiology of *Campylobacter* in dogs are important to know their role as a possible source of zoonosis. Despite evidence of increasing human campylobacteriosis over the last decade, there is paucity of research based knowledge on epidemiology of faecal *Campylobacter* shedding among dogs in India. Therefore, the study aimed to determine the prevalence of faecal *Campylobacter* among dogs, to estimate the specific prevalence of *C. jejuni*, to identify the associated risk factors and antimicrobial susceptibility pattern of *Campylobacter* spp. in dogs.

Materials and methods {#sec0002}
=====================

Study design and period {#sec0003}
-----------------------

A cross-sectional study was conducted at the department of Veterinary Epidemiology and Preventive Medicine, U. P. Pt. Deen Dayal Upadhyaya Pashu Chikitsa Vigyan Vishwavidyalaya Evam Go Anusandhan Sansthan (DUVASU), Mathura, India between 2013 and 2015. This university has referral Teaching Veterinary Clinical Complex (TVCC) that provides services to Uttar Pradesh and nearby states in India. Dogs belonging to breed such as Dobermann, Pomeranian, German shepherd, Spitz and non-descript breed visiting the TVCC for treatment during the study period were the source population. Dogs less than one year of age were considered as pups and one or more than one year were grouped as adults.

Sampling technique and data collection {#sec0004}
--------------------------------------

A total of 134 samples were collected from dogs that visited Teaching Veterinary Clinical Complex of Veterinary University, Mathura, India. Convenient sampling technique was used. After obtaining consent from the owner, faecal sample along with epidemiological data about the associated risk factors viz., breed, sex age, health status, co-habitation with other dogs and relevant clinical information were taken using pre-structured questionnaire. Rectal swab were collected from 134 dogs (male *n*  =  106; female *n*  =  28). Of the 134 dogs, 40 were healthy and 94 had diarrhoea. Dogs were divided into two age groups, namely, 1 year old or pups (*n*  =  80), and \> 1 year (*n*  =  52).

Sample collection and processing {#sec0005}
--------------------------------

Fresh rectal swabs were collected aseptically from each dog using sterile swabs and transported immediately to the laboratory on ice. Rectal swabs were inoculated in *Campylobacter* Enrichment HiVeg^TM^ Broth Base (HiMedia, Mumbai) supplemented with polymixin B sulphate, rifampicin, trimethoprim and cycloheximide and incubated at 42--43 °C for 24 h in 5% CO~2~ atmosphere using CO~2~ incubator. After incubation, the inoculums were streaked onto selective media (*Campylobacter* selective agar, HiMedia, Mumbai) supplemented with 10% lysed horse blood and reconstituted contents of *Campylobacter* selective-I (HiMedia, Mumbai) supplemented with polymixin B, vancomycin, trimethoprim and cephalothin. These were incubated again at 42--43 °C for 48 h under microaerophilic conditions with 5% CO~2~ concentration for the isolation of selective single colonies.

Identification of Campylobacter spp {#sec0006}
-----------------------------------

The identification of *Campylobacter* spp. was performed by characteristic appearance on culture medium (moist, creamy-grey and flat-spreading), Gram stain, oxidase (Oxidase disc, HiMedia, India) and catalase testing ([@bib0022], [@bib0046]). DNA extraction from bacterial cultures was performed by phenol chloroform method ([@bib0044]). For the molecular identification, primers were custom synthesized to amplify members of the *Campylobacter* genus (16S rRNA; [@bib0035]) and isolates of *C. jejuni* (*cj0414* gene; [@bib0055]) were used. The in vitro amplification of DNA was performed in thermocycler (Eppendorf, Germany) using an initial denaturation step at 95°C for 15 min; 25 cycles of denaturation (95°C for 30 s), annealing (58°C for 90 s) and extension (72°C for 1 min); and a final extension step at 72°C for 7 min. About 10 µl of the PCR product was analysed by 1.0% agarose gel electrophoresis.

Antimicrobial susceptibility test {#sec0007}
---------------------------------

All the confirmed *Campylobacter* isolates obtained and confirmed during the present study were examined for their drug resistance pattern by disc diffusion method ([@bib0008]) using 19 antibacterial discs (Hi-Media, Mumbai) viz., amikacin (30 µg), ampicillin (10 µg), amoxycillin (20 µg), aztreonam (30 µg), cefaclor (30 µg), cefotaxim (30 µg), ciprofloxacin (30 µg), chloramphenicol (30 µg), enrofloxacin (10 µg), gentamicin (10 µg), lincomycin (10 µg), nitrofurazone (100 µg), norfloxacin (10 µg), ofloxacin (5 µg), oxytetracycline (30 µg), pefloxacin (5 µg), penicillin (10units), streptomycin (10 µg) and tetracycline (30 µg) as described in Clinical and Laboratory Standards Institute (CLSI) guidelines ([@bib0013]).

Data processing and statistical analysis {#sec0008}
----------------------------------------

*Campylobacter* prevalence in dogs was stratified by the variables breed, sex, age (\< 1 year, ≥ 1 year), occurrence of diarrhoea and co-habitation with other dogs. The possible role of these variables as risk factors in *Campylobacter* colonization was evaluated by chi-square test ([@bib0047]). In all analyses, *P-*values less than 0.05 were taken as statistically significant.

Results {#sec0009}
=======

Prevalence of *Campylobacter* species {#sec0010}
-------------------------------------

Among 134 faecal specimens cultured, *Campylobacter* species were isolated and subsequently confirmed by PCR in 38 samples representing the prevalence of 28.36%. The most frequent species identified in the present study was *Campylobacter jejuni* (68.42%), while 12/38 (31.57%) were other *Campylobaceter* spp. ([Fig. 1](#fig0001){ref-type="fig"}).Fig. 1Species-specific PCR amplicons were resolved after electrophoresis through a 1% agarose gel.Lane M: 100 bp DNA ladder (in base pairs) is shown on the left-hand edge of the gel.Lane N: Negative controlLane 1-7: *Campylobacter jejuni* (650 bp) isolates.Fig 1

Possible risk factors and their association with *Campylobacter* infections {#sec0011}
---------------------------------------------------------------------------

Among the risk factors, sex and age showed no statistically significant association with *Campylobacter* culture positivity; whereas breed, health status and co-habitation with another dog had statistically significant association ([Table 1](#tbl0001){ref-type="table"}). The positive rate of *Campylobacter* infection was the highest in nondescript dogs (36.84%), followed by Doberman (36.36%), Pomeranian (33.33%), German shepherd (30.00%) and, Spitz (21.43%). Significantly higher prevalence of *Campylobacter* spp. (\> 3 times) had been observed in diarrhoeic dogs (34/94; 36.17%) compared to non-diarrheic dogs (04/40; 10.00%). The prevalence of *Campylobacter* spp. in dogs sharing their habitat (for example in kennels or shelter) (24/64; 37.50%) was significantly higher than individually reared dogs (14/70; 20.00%).Table 1*Campylobacter* spp. detection in dogs.Table 1Risk factors /VariablesCategoriesNumber of animals testedNumber of Positive animalsPercentage PositivityBreed[\*](#tb1fn1){ref-type="table-fn"}Boxer7114.29Bull mastiff200.00Doberman11436.36German Shepherd20630.00Labrador24416.67Pomeranian15533.33Rottweiller3133.33Spitz14321.43Nondescript381436.84Total1343828.36SexMale1063028.30Female28828.57Total1343828.36Age\< 1 year (Pups)822732.93≥ 1 year (Adult)521121.15Total1343828.36Diarrheic[\*](#tb1fn1){ref-type="table-fn"}Yes943436.17No40410.00Total1343828.36Cohabitation with other dog[\*](#tb1fn1){ref-type="table-fn"}Yes642437.50No701420.00Total1343828.36[^1]

Antimicrobial susceptibility patterns of the isolates {#sec0012}
-----------------------------------------------------

The results of antimicrobial susceptibility testing for *Campylobacter species* isolated from dogs against 19 selected antimicrobial agents are presented in [Table 2](#tbl0002){ref-type="table"}. Of the 19 antimicrobial drugs used to determine antibiogram of *Campylobacter* isolates, amoxycillin, ampicillin, aztreonam, cefotaxim, lincomycin, oxytetracycline, penicillin, streptomycin and tetracycline revealed no zone of inhibition suggestive of resistance in all the isolates against these nine drugs. It was followed by pefloxacin (92.11%), chloramphenicol (86.84%), ciprofloxacin (84.21%), nitrofurazone (78.94%), ofloxacin (76.32%), norfloxacin (73.68%) and cefaclor (73.68%) Only three out of 19 antibacterials, enrofloxacin, gentamicin and amikacin revealed zone of inhibition suggestive of sensitivity against 31.58%, 23.68% and 18.42% isolates, respectively.Table 2Antibiogram of *Campylobacter* spp. isolated from dogs.Table 2Number of isolates (38)Name of antibacterialSymbolRISSensitivity %Resistant %AmikacinAk16150718.4242.11AmoxycillinAm38----0100AmpicillinA38----0100AztreonamAt38----0100CefaclorCf28060410.5373.68CefotaximCe38----0100ChloramphenicolC3303025.2686.84CiprofloxacinCip3204025.2684.21EnrofloxacinEx16101231.5842.11GentamicinG23150923.6860.53LincomycinL38----0100NitrofurazoneNr3008--078.94NorfloxacinNx2810--073.68OfloxacinOf2908012.6376.32OxytetracyclineO38----0100PeefloxacinPf3503--092.11PenicillinP38----0100StreptomycinS38----0100TetracyclineT38----0100[^2]

Discussion {#sec0013}
==========

This study showed the prevalence of *Campylobacter* species in dogs presented to veterinary practices, and Mathura was 28.36%, that is within the range (4.81%--75%) of prevalence data previously reported ([@bib0010], [@bib0016], [@bib0021], [@bib0028], [@bib0031], [@bib0032], [@bib0033], [@bib0042], [@bib0045], [@bib0054]). The variation in prevalence could be due to differences in geographical location, differences in the populations investigated, or in the detection methods used ([@bib0002], [@bib0025], [@bib0041], [@bib0054]). The species distribution of *Campylobacter* isolates from dogs differs considerably among publications and years. The *C. jejuni* ([@bib0003], [@bib0004], [@bib0021]) and *C. upsaliensis* ([@bib0028], [@bib0040], [@bib0042], [@bib0045]) have been found to be the most common species in dogs. However, the season, geographical area, breeds etc may have different prevalence for different species. Most *Campylobacter* positive dogs in the present study were colonized by *C. jejuni.* This is an important finding from a public health standpoint, since *C. jejuni* is the species most frequently associated with human gastroenteritis ([@bib0018], [@bib0039]) and associated also with asymptomatic human disease ([@bib0050]) in middle income countries.

The distribution of *Campylobacter* species between male and females dogs was not statistically significant, that agrees with the previous studies ([@bib0004], [@bib0032], [@bib0033], [@bib0041], [@bib0054]), those also suggested that campylobacter colonization in dogs was not sex dependent.

The high prevalence of *Campylobacter*s in non-descript dogs in the present study was in agreement with the previous study ([@bib0054]). The possible reason of higher prevalence might be the way of living of non-descript dogs as these dogs used to roam outside the home freely leading to more exposure and chances of getting infection from stray dogs or animals in and around areas ([@bib0032], [@bib0054]). The high prevalence (39.3%) of *Campylobacter* spp. in wild birds ([@bib0057]) is of importance because nondescript dogs can easily meet the faeces of these infected birds during roaming in streets and parks.

Non-significant relationship was found between age and *Campylobacter* positive status. Similarly, the previous studies ([@bib0033], [@bib0052], [@bib0056]) also reported age as non predisposing factor for *Campylobacter* infection. However, contrary to the present findings, higher positivity of *Campylobacter* isolation in pups in comparison to adult dogs was reported in earlier studies ([@bib0001], [@bib0002], [@bib0016], [@bib0025], [@bib0028], [@bib0045], [@bib0054] [@bib0004]). These reports suggested younger dogs more likely to be carriers of *Campylobacter spp.* and to shed the bacteria more commonly than older dogs probably as consequence of age-related immunity ([@bib0029]). In Denmark, the incidence of *Campylobacter* spp. in particular *C. upsaliensis*, peaked at 13--15 months aged pet dogs ([@bib0026]). Another report suggested that age of dog had a quadratic effect, with young dogs and senior dogs having an increased probability of shedding *Campylobacter* spp. compared with adult dogs ([@bib0042].

In this study, diarrhoea had statistically significant association with isolation of *Campylobacter* species among dogs. This is consistent with the previous studies ([@bib0016], [@bib0045], [@bib0057]). However, in contrasts to these findings, several authors reported no association between *Campylobacter* infection and digestive disorders in dogs ([@bib0001], [@bib0021], [@bib0041]). Thus, such reports may call into question the presumed association of *Campylobacter* with gastrointestinal disease in dogs. In 2010, Parson and coworkers further suggested the presence of *Campylobacter* spp. in the faeces as an important risk indicator for diarrhoea in dogs. High infection rate was seen in dogs that shared their habitat with other dogs, indicating the direct association between *Campylobacter* spp. infection and pets. The present findings are in agreement with the findings of previous studies ([@bib0004], [@bib0025], [@bib0041]). The overcrowding, cross-infection, stress, frequent dietary changes might be the factors for increased incidence of gastrointestinal disease suffered by animals in pounds or kennels ([@bib0001], [@bib0002], [@bib0011], [@bib0051]). Contrary to this, several studies found no association between a dog\'s *Campylobacter* carrier status, and whether or not they lived with other animals ([@bib0001], [@bib0016], [@bib0026], [@bib0041], [@bib0045]), suggesting *Campylobacter* as a commensal ([@bib0016]).

Although gastroenteritis due to *Campylobacter* species is mostly mild and self-limiting in nature but occasionally severe dehydration become life-threatening and requires antibacterial treatment. In the present study, ninteen commonly used antibacterials were tested against 38 isolates of *Campylobacter* species. Majority of *Campylobacter* spp. isolates showed resistance to at least 3 of the antibacterials tested, indicating multi-drug resistance. In the present study, isolates were sensitive to amikacin (18.42%), gentamicin (23.68%) and enrofloxacin (31.58%). Among these, enrofloxacin are not prescribed for dogs due to their contradictions. The antimicrobial susceptibility test indicated that gentamicin and amikacin are the most efficient antibacterials against *Campylobacter* spp. isolated from dogs in vitro*.* A 100% of resistance of *Campylobacter* isolates against amoxicillin, amoxycillin, ampicillin, aztreonam, cefotaxim, lincomycin, oxytetracycline, penicillin, streptomycin and tetracycline was also observed. A high rate of resistance was observed against pefloxacin (92.11%), chloramphenicol (86.84%), ciprofloxacin (84.21%), nitrofurazone (78.94%), ofloxacin (76.32%), norfloxacin (73.68%) and cefaclor (73.68%). These results are consistent with other studies in dogs, which found low resistance to gentamicin and medium-high resistances to quinolones (ciprofloxacin and nalidixic acid), cephalosporins, and tetracyclines ([@bib0015], [@bib0034]). This high rate may be due to indiscriminate use of these drugs in the studied area that leads to increased resistance.

Similarly resistance to tetracycline with *Campylobacter* isolates from humans, dogs and other animals were reported in the range of 15--94% ([@bib0014], [@bib0019], [@bib0043]). The concurrence to previous reports of high resistance to ampi-cloxacillin for *Campylobacter* spp. i.e. 57.3% ([@bib0036]) and 65.7% ([@bib0043]) in pigs and 43.1% ([@bib0027]) and 40.8% ([@bib0038]) in chicken, the resistance to ampi-cloxacillin was recorded 88.23%.

All the *Campylobacter* isolates showed resistance to cefotaxim, and this is alarming because it is the 3rd generation cephalosporin and is the drug of choice for local vets in the treatment of diarrhoea and gastroenteritis in pets. An increased resistance to quinolones is probably due to genetic mutations interfering with bacterial DNA gyrase ([@bib0024]). Selective pressure caused by the indiscriminate use of these drugs in aviculture might be a contributory factor. Previous studies ([@bib0009], [@bib0043]) reported the highest resistance of *Campylobacter* isolates to quinolones among various antibacterials similar to results obtained in the current study with 80.39% of the isolates resistant to ciprofloxacin. Contrary to our findings, different reports showed 100% sensitivity to ciprofloxacin in *Campylobacter spp*. isolated from chicken in Australia ([@bib0038]); domestic animals and poultry in India ([@bib0007]); isolates from environmental samples ([@bib0006]). A report from Canada showed only 0.3% resistance against ciprofloxacin in cattle isolates ([@bib0030]). The resistance patterns displayed by *Campylobacter* isolates in dogs to fluoroquinolone (ciprofloxacin) and macrolides (erythromycin) classified as second line. The first line antimicrobials like aminoglycosides and cephalosporins are of particular importance, since patients suffering from campylobacteriosis are usually treated with these antimicrobials agents ([@bib0053]). The resistance to chloramphenicol was also observed previously in humans ([@bib0005]) and chickens ([@bib0038]). The great variability in this antibacterial\'s efficacy is probably due to its worldwide use in cattle, both at therapeutic or low doses; this would increase selective pressure on bacteria.

Recent scientific studies have shown that campylobacter antimicrobial resistance are related to some specific genes, and the dissemination of these genes of microorganisms to their progeny and across to other unrelated co-habitat bacterial species through extrachromosomal DNA fragment called the plasmid ([@bib0006]). Antimicrobial resistance particularly multi drug resistance observed in the present work might be due to the indiscriminate and irrational use of antimicrobials ([@bib0048]) in animals for preventive or therapeutic purposes irrespective of etiological agents.

Conclusion {#sec0014}
==========

The present study indicates a high prevalence of *Campylobacter* species particularly of *C. jejuni* among dogs. *C.* *jejuni,* the most frequently associated with the occurrence of the disease in humans are present in Indian dogs. The prevalence was higher in dogs of nondescript breed, pups and dogs sharing their habitat. The high rate of antibacterial resistance and higher percentage of multi durg resistant isolates may be due to frequent prescription of drugs without drug susceptibility testing and inappropriate usage of the commonly available drugs in the market. There is an urgent need to develop awareness strategies of the *Campylobacter* risk from dogs to reduce its transmission from dogs to children and immunocompromised human beings.
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[^1]: Significant at (*P* \< 0.05)

[^2]: S- Sensitivity, I -- Intermediate, R- Resistant (based on chart provided by manufacturer
